These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of pulmonary vascular responses to chronic hypoxia in the development of chronic mountain sickness in rats. Hill NS, Ou LC. Respir Physiol; 1984 Nov; 58(2):171-85. PubMed ID: 6240752 [Abstract] [Full Text] [Related]
8. Ventilatory responses and blood gases in susceptible and resistant rats to high altitude. Ou LC, Hill NS, Tenney SM. Respir Physiol; 1984 Nov; 58(2):161-70. PubMed ID: 6240751 [Abstract] [Full Text] [Related]
9. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. van Suylen RJ, Smits JF, Daemen MJ. Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118 [Abstract] [Full Text] [Related]
10. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats. Horstman DJ, Frank DU, Rich GF. Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855 [Abstract] [Full Text] [Related]
12. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats. Tofovic PS, Zhang X, Petrusevska G. Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529 [Abstract] [Full Text] [Related]
13. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Penaloza D, Arias-Stella J. Circulation; 2007 Mar 06; 115(9):1132-46. PubMed ID: 17339571 [Abstract] [Full Text] [Related]
14. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Partovian C, Adnot S, Eddahibi S, Teiger E, Levame M, Dreyfus P, Raffestin B, Frelin C. Am J Physiol; 1998 Dec 06; 275(6):H1948-56. PubMed ID: 9843792 [Abstract] [Full Text] [Related]
15. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension. Mathew R, Gloster ES, Sundararajan T, Thompson CI, Zeballos GA, Gewitz MH. J Appl Physiol (1985); 1997 May 06; 82(5):1493-8. PubMed ID: 9134898 [Abstract] [Full Text] [Related]
16. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats. Zopf DA, das Neves LA, Nikula KJ, Huang J, Senese PB, Gralinski MR. Eur J Pharmacol; 2011 Nov 16; 670(1):195-203. PubMed ID: 21914448 [Abstract] [Full Text] [Related]
17. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924 [Abstract] [Full Text] [Related]
18. Role of sex hormones in development of chronic mountain sickness in rats. Ou LC, Sardella GL, Leiter JC, Brinck-Johnsen T, Smith RP. J Appl Physiol (1985); 1994 Jul 25; 77(1):427-33. PubMed ID: 7961265 [Abstract] [Full Text] [Related]
19. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]. Tabata T, Ono S, Song C, Noda M, Suzuki S, Tanita T, Fujimura S. Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb 25; 35(2):160-6. PubMed ID: 9103852 [Abstract] [Full Text] [Related]
20. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension. Christou H, Reslan OM, Mam V, Tanbe AF, Vitali SH, Touma M, Arons E, Mitsialis SA, Kourembanas S, Khalil RA. Am J Physiol Lung Cell Mol Physiol; 2012 May 01; 302(9):L875-90. PubMed ID: 22287610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]